文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

急性冠脉综合征所致心脏骤停患者体外心肺复苏中使用主动脉内球囊反搏的30天结局

Intra-aortic balloon pump in patients with extracorporeal cardiopulmonary resuscitation after cardiac arrest caused by acute coronary syndrome.
PubMed 文献 · Resuscitation · 2023-12-13
一句话结论ACS所致OHCA接受ECPR者中,IABP使用与30天生存无显著相关(OR 1.37,95%CI 0.91-2.07,p=0.13);未行PCI且多支冠脉狭窄者使用IABP的关联需进一步研究。

本研究为SAVE-J II研究(日本36家机构参与的回顾性多中心登记研究)的二次分析,纳入ACS所致心脏骤停并接受ECPR的患者877例,按是否使用IABP分为IABP组702例与非IABP组175例,主要终点为30天生存。多因素logistic回归分析未显示IABP使用与30天生存显著相关(OR 1.37,95%CI 0.91-2.07,p=0.13)。亚组分析中,未行经皮冠状动脉介入治疗(PCI)且存在多支冠脉狭窄的患者,其30天生存与IABP使用相关。结论认为ACS所致OHCA接受ECPR者中IABP使用与30天生存无关,未行PCI且多支冠脉狭窄者使用IABP的关联需进一步研究。

要点

  • ACS所致OHCA接受ECPR患者中,IABP组702例与非IABP组175例的30天生存无显著差异(OR 1.37,95%CI 0.91-2.07,p=0.13)。
  • 亚组分析显示,未行PCI且存在多支冠脉狭窄的患者中,30天生存与IABP使用相关。
  • 作者认为,未行PCI且多支冠脉狭窄者使用IABP的关联需进一步研究。

适用人群与场景

  • 日本36家机构参与的SAVE-J II研究中,因急性冠脉综合征(ACS)导致心脏骤停并接受体外心肺复苏(ECPR)的患者,共877例(IABP组702例,非IABP组175例)。

研究设计与关键结果

  • 研究类型:SAVE-J II研究(日本36家机构参与的回顾性多中心登记研究)的二次分析;纳入ACS所致心脏骤停接受ECPR患者877例,按是否使用IABP分为IABP组702例与非IABP组175例。
  • 主要终点:多因素logistic回归分析未显示IABP使用与30天生存显著相关(OR 1.37,95%CI 0.91-2.07,p=0.13)。
  • 亚组分析:未行PCI且存在多支冠脉狭窄的患者中,30天生存与IABP使用相关。

证据类型、等级与局限

  • 证据类型:回顾性、多中心登记研究的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,ACS所致OHCA接受ECPR患者使用IABP与30天生存无关;未行PCI且多支冠脉狭窄者使用IABP的关联需进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: This study evaluated the association between intra-aortic balloon pump (IABP) use in patients with out-of-hospital cardiac arrest (OHCA) caused by acute coronary syndrome (ACS) who received extracorporeal cardiopulmonary resuscitation (ECPR) and 30-day outcomes.

METHODS: This study was a secondary analysis of data from the SAVE-J II study, a retrospective, multicenter registry study involving 36 participating institutions in Japan. Patients with cardiac arrest caused by ACS who received ECPR were divided into two groups depending on whether or not they received IABP. The primary outcome was 30-day survival. Subgroup analysis was performed to detect what type of patients were mostly associated with improved outcomes.

RESULTS: Of 2,157 patients registered in the SAVE-J II study, 877 patients were enrolled in this study, 702 patients in the IABP group and 175 patients in the non-IABP group. Multivariable logistic regression analysis did not reveal a significant difference in 30-day survival (OR 1.37, 95% CI 0.91-2.07, p = 0.13). In the subgroup analysis, 30-day survival among patients without percutaneous coronary intervention (PCI) and stenosis of multiple coronary vessels were associated with IABP use.

CONCLUSIONS: IABP use in patients with OHCA with ACS who received ECPR is not associated with 30-day survival. The use of IABP in patients who did not have PCI and have multiple coronary vessel stenoses warrants further study.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Nishimura T, Inoue A, Taira T, et al. Intra-aortic balloon pump in patients with extracorporeal cardiopulmonary resuscitation after cardiac arrest caused by acute coronary syndrome. Resuscitation. 2023. PMID: 38101507. doi:10.1016/j.resuscitation.2023.110091

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。